What this means
Researchers plan to test whether three questionnaires work well in Uzbek for men aged 35 to 59. The study has not reported results, so it does not yet show whether they are reliable.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 35–59 · About 400 men aged 35-59 in the Andijan region of Uzbekistan
- Where
- 1 site
The science
- Registered title
- Validation of Uzbek-Language ADAM, AMS, and IPSS Questionnaires in Men Aged 35-59 Years
- Trial ID
- NCT07879183 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Psychometric Validation of Men's Health Questionnaires
- Sponsor
- Andijan State Medical Institute
- Ages
- 35 Years to 59 Years
- Dates
- First posted Oct 16, 2026 · updated Oct 16, 2026
Registry summary
This observational study aims to evaluate the reliability and validity of the Uzbek-language versions of three questionnaires used to assess men's health: the Androgen Deficiency in Aging Males (ADAM), Aging Males' Symptoms (AMS), and International Prostate Symptom Score (IPSS).
The study will include approximately 400 men aged 35-59 years from the Andijan region of Uzbekistan. Participants will complete all three questionnaires electronically using Google Forms. At least 120 participants will complete the questionnaires again after 7-14 days to assess the consistency of their responses.
Blood samples will be collected to measure total testosterone levels and examine their relationship with questionnaire results. The study will also assess how well ADAM identifies men with low testosterone levels and how reliably AMS and IPSS measure their respective symptoms.
No treatment or experimental intervention will be administered. The findings will help determine whether these Uzbek-language questionnaires are suitable for use in clinical practice and future research.
Sites (1)
- Andijan State Medical Institute, Andijan, Uzbekistan